Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells von Madlener, Sibylle, Illmer, Christoph, Horvath, Zsuzsanna, Saiko, Philipp, Losert, Annemarie, Herbacek, Irene, Grusch, Michael, Elford, Howard L, Krupitza, Georg, Bernhaus, Astrid, Fritzer-Szekeres, Monika, Szekeres, Thomas

Volltext

The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML von Cook, Guerry J, Caudell, David L, Elford, Howard L, Pardee, Timothy S

Volltext

Targeting the Cell Cycle, RRM2 and NF-κB for the Treatment of Breast Cancers von Sultana, Nahid, Elford, Howard L, Faridi, Jesika S

Volltext

Molecular Targeting of RRM2, NF-κB, and Mutant TP53 for the Treatment of Triple-Negative Breast Cancer von Wilson, Elizabeth A, Sultana, Nahid, Shah, Khyati N, Elford, Howard L, Faridi, Jesika S

Volltext

Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer von Shah, Khyati N, Wilson, Elizabeth A, Malla, Ritu, Elford, Howard L, Faridi, Jesika S

Volltext

Abstract 4689: Successfully targeting triple negative breast cancer using combination therapy of Didox and Doxorubicin with reduced cardiotoxicity von Wilson, Elizabeth A., Elford, Howard L., Faridi, Jesika S.

Volltext

Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and Trimidox von Inayat, Mohammed S, El-Amouri, Ismail S, Bani-Ahmad, Mohammad, Elford, Howard L, Gallicchio, Vincent S, Oakley, Oliver R

Volltext

Didox (3,4-dihydroxybenzohydroxamic acid) reduces the vascular inflammation induced by acute intravascular hemolysis von Silva, Juliete A.F., Gotardo, Érica M.F., Chweih, Hanan, Miguel, Lediana I., Ferreira, Wilson A., Hedlund, Bo, Elford, Howard L., Leonardo, Flavia C., Costa, Fernando F., Conran, Nicola

Volltext

Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription von McLeod, Jamie Josephine Avila, Caslin, Heather L., Spence, Andrew J., Kolawole, Elizabeth M., Qayum, Amina Abdul, Paranjape, Anuya, Taruselli, Marcela, Haque, Tamara T., Kiwanuka, Kasalina N., Elford, Howard L., Ryan, John J.

Volltext

Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells von Caslin, Heather L., McLeod, Jamie Josephine Avila, Spence, Andrew J., Qayum, Amina Abdul, Kolawole, Elizabeth Motunrayo, Taruselli, Marcela T., Paranjape, Anuya, Elford, Howard L., Ryan, John J.

Volltext

Didox (A Novel Ribonucleotide Reductase Inhibitor) Overcomes bcl-2 Mediated Radiation Resistance in Prostate Cancer Cell Line PC-3 von Inayat, Mohammed S., Chendil, Damodaran, Mohiuddin, Mohammed, Elford, Howard L., Gallicchio, Vincent S., Ahmed, Mansoor M.

Volltext

Antimalarial Activities of Polyhydroxyphenyl and Hydroxamic Acid Derivatives von HOLLAND, K. P, ELFORD, H. L, BRACCHI, V, ANNIS, C. G, SCHUSTER, S. M, CHAKRABARTI, D

Volltext

Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells von Fritzer-Szekeres, Monika, Grusch, Michael, Luxbacher, Cornelia, Horvath, Susanna, Krupitza, Georg, Elford, Howard L, Szekeres, Thomas

Volltext

Abstract 1240: RRM2 and mutant p53 as therapeutic targets in TNBC von Sultana, Nahid, Wilson, Elizabeth A., Elford, Howard L., Faridi, Jesika S.

Volltext

Abstract 5212: The benefits of Didox in triple negative breast cancer treatment targeting mutant p53 von Sultana, Nahid, Wilson, Elizabeth A., Shah, Khyati N., Elford, Howard L., Faridi, Jesika S.

Volltext

Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice von Novotny, Ladislav, Rauko, Peter, Liska, Jan, Elford, Howard L., Szekeres, Thomas

Volltext

Ribonucleotide Reductase Inhibitors Reduce Atherosclerosis in a Double-Injury Rabbit Model von Gallaugher, Laura D, Henry, Jon C, Kearns, Patrick N, Elford, Howard L, Bergdall, Valerie K, Cardounel, Arturo J

Volltext

Abstract 5989: Targeting RRM2 & cell cycle for breast cancer treatment von Sultana, Nahid, Elford, Howard L., Faridi, Jesika S.

Volltext

Abstract P1-13-01: Targeting RRM2 for the treatment of palbociclib resistant breast cancer von Sultana, Nahid, Elford, Howard L., Faridi, Jesika S.

Volltext

Paradoxical response to prophylactic Didox (N-3, 4 trihydroxybenzamide) treatment in murine cytomegalovirus-infected mice von GO, Vera, TANG-FELDMAN, Yajarayma J, LOCHHEAD, Stephanie R, LOCHHEAD, G. Raymond, YU, Cindy Q, ELFORD, Howard L, INAYAT, Mohammed S, OAKLEY, Oliver R, POMEROY, Claire

Volltext